EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access

Screening for Breast Cancer

Jillian T Henderson, Elizabeth M Webber, Meghan S Weyrich, Marykate Miller, Joy Melnikow

JAMA · 11.06.2024 · 331 (22) · 1931

DOI: 10.1001/jama.2023.25844 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift JAMA, erschienen am 11.06.2024. Verfasst von Jillian T Henderson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Kaiser Permanente Evidence-based Practice Center, Center for Health Research, Portland, Oregon. Hauptthemen laut MEDLINE: Breast Neoplasms, Mammography, Early Detection of Cancer. Die Arbeit wurde bisher 112-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Breast cancer is a leading cause of cancer mortality for US women. Trials have established that screening mammography can reduce mortality risk, but optimal screening ages, intervals, and modalities for population screening guidelines remain unclear.

Objective

To review studies comparing different breast cancer screening strategies for the US Preventive Services Task Force. Data Sources MEDLINE, Cochrane Library through August 22, 2022; literature surveillance through March 2024. Study Selection English-language publications; randomized clinical trials and nonrandomized studies comparing screening strategies; expanded criteria for screening harms. Data Extraction and Synthesis Two reviewers independently assessed study eligibility and quality; data extracted from fair- and good-quality studies. Main Outcomes and Measures Mortality, morbidity, progression to advanced cancer, interval cancers, screening harms.

Results

Seven randomized clinical trials and 13 nonrandomized studies were included; 2 nonrandomized studies reported mortality outcomes. A nonrandomized trial emulation study estimated no mortality difference for screening beyond age 74 years (adjusted hazard ratio, 1.00 [95% CI, 0.83 to 1.19]). Advanced cancer detection did not differ following annual or biennial screening intervals in a nonrandomized study. Three trials compared digital breast tomosynthesis (DBT) mammography screening with digital mammography alone. With DBT, more invasive cancers were detected at the first screening round than with digital mammography, but there were no statistically significant differences in interval cancers (pooled relative risk, 0.87 [95% CI, 0.64-1.17]; 3 studies [n = 130 196]; I 2 = 0%). Risk of advanced cancer (stage II or higher) at the subsequent screening round was not statistically significant for DBT vs digital mammography in the individual trials. Limited evidence from trials and nonrandomized studies suggested lower recall rates with DBT. An RCT randomizing individuals with dense breasts to invitations for supplemental screening with magnetic resonance imaging reported reduced interval cancer risk (relative risk, 0.47 [95% CI, 0.29-0.77]) and additional false-positive recalls and biopsy results with the intervention; no longer-term advanced breast cancer incidence or morbidity and mortality outcomes were available. One RCT and 1 nonrandomized study of supplemental ultrasound screening reported additional false-positives and no differences in interval cancers. Conclusions and Relevance Evidence comparing the effectiveness of different breast cancer screening strategies is inconclusive because key studies have not yet been completed and few studies have reported the stage shift or mortality outcomes necessary to assess relative benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMammographyEarly Detection of CancerHumansFemaleAgedMiddle AgedUltrasonography, MammaryMass ScreeningUnited StatesPractice Guidelines as Topic

Autor:innen und Institutionen

  • Kaiser Permanente Evidence-based Practice Center, Center for Health Research, Portland, Oregon.
  • University of California Davis Center for Healthcare Policy and Research, Sacramento.

Zitieren

APA

Henderson, J. T., Webber, E. M., Weyrich, M. S., Miller, M., & Melnikow, J. (2024). Screening for Breast Cancer. JAMA, 331(22), 1931. https://doi.org/10.1001/jama.2023.25844

Vancouver

Henderson JT, Webber EM, Weyrich MS, Miller M, Melnikow J. Screening for Breast Cancer. JAMA. 2024;331(22):1931. doi:10.1001/jama.2023.25844

BibTeX
@article{Henderson2024,
  author = {Henderson, Jillian T and Webber, Elizabeth M and Weyrich, Meghan S and Miller, Marykate and Melnikow, Joy},
  title = {Screening for Breast Cancer},
  journal = {JAMA},
  year = {2024},
  volume = {331},
  number = {22},
  pages = {1931},
  doi = {10.1001/jama.2023.25844}
}
Kostenlos starten →